Clincosm LogoSign in Get a demo

Solid Tumors

Showing NaN - NaN of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)

Active, not recruiting
  • Ovarian Cancer
  • +3 more
  • Duarte, California
  • +6 more
Jan 21, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +19 more
Jan 18, 2023

Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

Terminated
  • Solid Tumors
  • NHL
  • Los Angeles, California
  • +7 more
Jan 18, 2023

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Daphne, Alabama
  • +156 more
Jan 13, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Solid Tumors, Melanoma, NSCLC Trial in France, Spain, United States (CFT1946, Trametinib)

Recruiting
  • Solid Tumors
  • +4 more
  • Boston, Massachusetts
  • +9 more
Dec 19, 2022

Genomic Profiling in Cancer Patients

Recruiting
  • Solid Tumors
  • Hematologic Cancers
  • molecular profiling of tumors
  • Clinical Germline Analysis
  • Bridgeport, Connecticut
  • +17 more
Dec 28, 2022

Solid Tumors Trial in Worldwide (INCB0123667)

Recruiting
  • Solid Tumors
  • Duarte, California
  • +34 more
Dec 12, 2022

Solid Tumors, Cancer Trial in Worldwide (MEDI1191, Durvalumab)

Active, not recruiting
  • Solid Tumors
  • Cancer
  • MEDI1191
  • Durvalumab
  • La Jolla, California
  • +13 more
Nov 30, 2022

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Solid Tumors, Identified by NGS, PCR or IHC Trial in United States (Pembrolizumab)

Recruiting
  • Solid Tumors
  • Identified by NGS, PCR or IHC
  • Basking Ridge, New Jersey
  • +6 more
Oct 7, 2022

Solid Tumors Trial in United States (mRNA-4157, Pembrolizumab)

Recruiting
  • Solid Tumors
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +9 more
Sep 20, 2022

Solid Tumors Trial in Worldwide (Cobimetinib)

Completed
Has Results
  • Solid Tumors
  • Little Rock, Arkansas
  • +16 more
Sep 14, 2022

Solid Tumors Trial in New York (procedure, drug, device, genetic)

Active, not recruiting
  • Solid Tumors
  • Production of Genetically-modified T cells
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 1, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Orange, California
  • +38 more
Aug 24, 2022

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

Solid Tumors Trial in Worldwide (Pembrolizumab, Standard of Care (SOC))

Recruiting
  • Solid Tumors
  • Tucson, Arizona
  • +374 more
Aug 22, 2022

Solid Tumors Trial in United States (Proton Therapy, Photon Therapy, SRS, Brachytherapy)

Recruiting
  • Solid Tumors
  • Proton Therapy, Photon Therapy, SRS, Brachytherapy
  • Birmingham, Alabama
  • +18 more
Aug 16, 2022

Solid Tumors Trial in United States (RAIN-32)

Recruiting
  • Solid Tumors
  • Palo Alto, California
  • +9 more
Aug 16, 2022

Solid Tumors Trial in United States (RMC-5552)

Recruiting
  • Solid Tumors
  • Irvine, California
  • +7 more
Aug 9, 2022

Solid Tumors Trial in France, United States (MEDI9253, Durvalumab)

Recruiting
  • Solid Tumors
  • MEDI9253
  • Durvalumab
  • La Jolla, California
  • +19 more
Jul 28, 2022

Solid Tumors, Lymphoma Trial in Worldwide (Ulevostinag, Pembrolizumab)

Completed
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +18 more
Jun 10, 2022